Harrow, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol: HROW, HROWL, HROWM on Nasdaq
Industry: Pharmaceutical Preparations
Location: 102 Woodmont Blvd, Suite 610, Nashville, Tennessee

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+232K	100%	$10.81	+$2.5M
Sells	0
Net	+2	+232K	100%		+$2.5M

Harrow, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Opaleye Management Inc.	10%+ Owner	$38M	+$2.34M	+6.55%	Apr 25, 2024
Mark L. Baum	CHIEF EXECUTIVE OFFICER, Director	$24.8M	+$165K	+0.67%	Mar 22, 2024
Andrew R. Boll	Chief Financial Officer	$6.06M			Feb 20, 2024
John P. Saharek	CEO of ImprimisRx	$2.23M			Mar 1, 2024
Richard L. Md Lindstrom	Director	$1.02M			Sep 30, 2022
Martin A. Makary	Director	$365K			Jun 14, 2024
Teresa Sparks	Director				Jun 21, 2023
R. Lawrence Van Horn	Director				Jun 21, 2023
Robert Kammer	Director				Jun 25, 2021
Perry J. Sternberg	Director				Jun 14, 2024
Lauren P. Silvernail	Director				Jun 14, 2024
Adrienne L. Graves	Director				Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Harrow, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.